LANZ

Lancer Orthodontics, Inc. LANZ

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode LANZ REMI CYPS DGEN NMRD EMGE VIVE RGDXQ CANQF UPH
6M -85.00 % -99.00 % 400.00 % 0.00 % -50.00 % -90.00 % -50.00 % 0.00 % -99.47 % -81.93 %
YTD -85.00 % -99.67 % 400.00 % 0.00 % 0.00 % -88.76 % -50.00 % 0.00 % -99.50 % 25.65 %
1Y -95.00 % -99.60 % 400.00 % 0.00 % 0.00 % -91.30 % -100.00 % 0.00 % -99.70 % -87.29 %
3Y -97.50 % -99.88 % -80.00 % 0.00 % -100.00 % -98.55 % -100.00 % 0.00 % -99.96 % -99.72 %
5Y -99.75 % -99.86 % -93.33 % -99.00 % -100.00 % -99.93 % -100.00 % -96.67 % -99.92 % -99.69 %
10Y -99.50 % -99.92 % -85.71 % -98.33 % -100.00 % -99.88 % -100.00 % -98.57 % -99.99 % -99.69 %
From the beginning -99.94 % -99.99 % -90.91 % -100.00 % -100.00 % -99.99 % -100.00 % -100.00 % -99.99 % -99.69 %

Dividend

Deltagen Inc.